Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRICIDIA: Pump vs Injections in Type 2 Diabetes
NCT02048189Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Mar 2012
- Primary completion
- Feb 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin detemir, insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Mar 2012; status: terminated.
02
Drugs
insulin detemirinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02048189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048189.